Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the treatment of disease and injuries. The company is headquartered in Beijing, Beijing and currently employs 18 full-time employees. The firm focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The firm also offers stem cell related services including cell testing and health management consulting services.
Yubo International Biotech Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Yubo International Biotech Ltd 주요 수익원은 Health Management and Health Maintenance Services이며, 최신 수익 발표에서 수익은 604,676입니다. 지역별로는 China이 Yubo International Biotech Ltd의 주요 시장이며, 수익은 604,676입니다.
Yubo International Biotech Ltd은 수익성이 있나요?
no, 최신 재무제표에 따르면 Yubo International Biotech Ltd의 순손실은 $-1입니다.
Yubo International Biotech Ltd에 부채가 있나요?
예, Yubo International Biotech Ltd의 부채는 3입니다.
Yubo International Biotech Ltd의 발행 주식은 몇 주인가요?
Yubo International Biotech Ltd의 총 발행 주식은 119.82주입니다.